Correlation Between Navidea Biopharmaceutica and Sigilon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Sigilon Therapeutics, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Sigilon Therapeutics.
Diversification Opportunities for Navidea Biopharmaceutica and Sigilon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Navidea and Sigilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Sigilon Therapeutics go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and Sigilon Therapeutics
If you would invest (100.00) in Sigilon Therapeutics on December 3, 2024 and sell it today you would earn a total of 100.00 from holding Sigilon Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Navidea Biopharmaceuticals vs. Sigilon Therapeutics
Performance |
Timeline |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Sigilon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Navidea Biopharmaceutica and Sigilon Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Navidea Biopharmaceutica and Sigilon Therapeutics
The main advantage of trading using opposite Navidea Biopharmaceutica and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |